Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), bought 140 shares at $84.95 ($12K) on 2012-03-05, disclosed to the SEC on 2013-12-11.
Open-market purchase of $12k ALXN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |